Jon Garfield - 09 May 2023 Form 4 Insider Report for Blue Water Biotech, Inc. (ONCO)

Reporting relationship: Chief Financial Officer
Issuer ticker: ONCO
Reported as of: 09 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 May 2023, 21:21:00 UTC
Prior SEC filing: 27 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Jon Garfield

Key filing fact

Jon Garfield filed Form 4 for Blue Water Biotech, Inc. (ONCO) on 11 May 2023.

Key facts

This page summarizes Jon Garfield's Form 4 filing for Blue Water Biotech, Inc. (ONCO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 May 2023, 21:21.

Change

Previous filing in this sequence was filed on 27 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWV transaction

Common Stock

Award

Transaction value
Shares: +100,000
Change %
Price
Shares after: 100,000
Date: 09 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025.